FDA clears IND for injectable anti-PD-L1

3DMed (Shanghai, China) and Suzhou Alphamab Co. Ltd. (Suzhou, China) said FDA cleared an IND for KN035, a subcutaneous anti-PD-L1 single domain antibody fused to an Fc...